Repeated Lipopolysaccharide (LPS) or Cytokine Treatments Sensitize Ethanol Withdrawal-Induced Anxiety-Like Behavior
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Previous investigations demonstrated that repeated stresses before an ethanol exposure sensitize ethanol withdrawal-induced anxiety-like behavior ('anxiety'). In addition to activating the hypothalamic-pituitary-adrenal axis, acute stress also elevates cytokines in brain. Initially, to test possible cytokine involvement in this stress/withdrawal protocol, cytokines were increased in brain with 2 weekly repeated lipopolysaccharide (LPS) administrations (1000 microg/kg) [corrected] (LPS/withdrawal protocol) or with twice weekly intracerebroventricular (i.c.v.) administrations of the cytokines IL-1 beta, CCL2 (MCP-1) or TNFalpha (cytokine/withdrawal protocol) before exposure and withdrawal from a 5-day cycle of chronic ethanol diet. Both protocols sensitized withdrawal-induced anxiety and confirm cytokine involvement in the sensitized anxiety response. Testing of various doses of LPS (16-1000 microg/kg) and TNFalpha (3-100 ng, i.c.v.) demonstrated the dose-related nature of these protocols to sensitize withdrawal-induced anxiety. The sensitized anxiety was not produced by a single 5-day ethanol diet cycle or by repeated LPS or cytokine treatments alone. Likewise, sensitized anxiety in these protocols could not be attributed to differences in ethanol ingestion. When challenged with a subsequent re-exposure to a 5-day ethanol diet cycle 16 days after completion of the LPS/withdrawal or cytokine/withdrawal protocols, an increase in withdrawal-induced anxiety was observed-an indication of induction of an underlying persistent adaptive change. Finally, just as found previously with the stress/withdrawal protocol, administration of the benzodiazepine receptor antagonist flumazenil before the LPS or TNF treatments prevented anxiety sensitization. Together, these findings indicate that increased cytokine activity induces adaptive change that supports sensitization of ethanol withdrawal-induced anxiety that may be linked to GABA(A)-receptor function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Injections of TNFa in the amygdala in rats increased anxiety-like behavior and mimicked the amplification of anxiety-like behavior that was observed with repeated cycles of alcohol drinking (Breese et al., 2008).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Breese et al., 2008
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“One overlapping aspect of acute stress (Carrasco and Van de Kar, 2003; Vale et al, 1981; Rivest and Rivier, 1994) and acute ethanol (Rivier et al, 1984; Rivier, 1996) is an effect on the hypothalamic– pituitary–adrenal (HPA) axis.”
BackgroundVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · cited 1×
“These findings led to the hypothesis that cytokines are involved in depressive illness (Anisman and Merali, 2003; Dunn et al, 2005; Hayley et al, 2005; Raison et al, 2006; Simen et al, 2006) and addictive behavior (Crews et al, 2006; Friedman and Eisenstein, 2004).”
BackgroundHow does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504 · cited 3×
“Although early studies implicated cytokines in the release of CRF and HPA axis activation (Berkenbosch et al, 1987; Sapolsky et al, 1987; Takemura et al, 1997; Turnbull et al, 1997; see review in Turnbull and Rivier, 1995, 1999a, b), the possibility that cytokines might be involved in the adaptive…”
BackgroundRegulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297 · cited 2×
“…including ‘sickness behavior’ (Kent et al, 1992; Bluthe et al, 1992; Fiore et al, 1998), fever, altered emotional behavior (Anisman and Merali, 2003; Yamada et al, 2000), and changes in endocrine function (Connor et al, 1998; Dunn et al, 2005; Turnbull and Rivier, 1999a, b; Watkins et al, 1995).”
BackgroundCorticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151 · cited 1×
“Although early studies implicated cytokines in the release of CRF and HPA axis activation (Berkenbosch et al, 1987; Sapolsky et al, 1987; Takemura et al, 1997; Turnbull et al, 1997; see review in Turnbull and Rivier, 1995, 1999a, b), the possibility that cytokines might be involved in the adaptive…”
BackgroundThe neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965 · cited 2×
“…of cytokines in these acute symptoms, cytokines may be involved in symptoms of depressive illness and negative affect (Anisman and Merali, 1999, 2003; Bonaccorso et al, 2003; Dunn et al, 2005; Millan, 2003; Pucak and Kaplin, 2005; Smith, 1991) and addictive behavior (Friedman and Eisenstein, 2004).”
BackgroundThe macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · cited 2×
“…of cytokines in these acute symptoms, cytokines may be involved in symptoms of depressive illness and negative affect (Anisman and Merali, 1999, 2003; Bonaccorso et al, 2003; Dunn et al, 2005; Millan, 2003; Pucak and Kaplin, 2005; Smith, 1991) and addictive behavior (Friedman and Eisenstein, 2004).”
Background
Cited by
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“Injections of TNFa in the amygdala in rats increased anxiety-like behavior and mimicked the amplification of anxiety-like behavior that was observed with repeated cycles of alcohol drinking (Breese et al., 2008).”
The role of neuroimmune signaling in alcoholism
Crews, F. T., Lawrimore, C. J., Walter, T. J., & Coleman, L. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.031 · Cited by 321
Induction of innate immune genes in brain create the neurobiology of addiction
Crews, F. T., Zou, J., & Qin, L. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.03.003 · Cited by 313
Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework
Koob, G. F., & Colrain, I. M. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0446-0 · Cited by 276
Breese, G. R., Sinha, R., & Heilig, M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.007 · Cited by 261
“Given these observations, the possibility is likely that cytokines released by stress contribute to the mediation of stress sensitization of alcohol withdrawal-induced symptoms (Breese et al., 2008).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Breese, G. R., Knapp, D. J., Overstreet, D. H., Navarro, M., Wills, T. A., & Angel, R. A.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Breese, George R
- Venue
- Neuropsychopharmacology
- Published
- 2007-06-06
- Volume
- 33
- Issue
- 4
- Pages
- 867-876
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC2268634
- OpenAlex
- W2023536806
- Cited by
- 110
- References
- 90
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 11 · 2020: 7 · 2019: 12 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 6 · 2014: 3 · 2013: 4 · 2012: 11
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-05-13)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institute on Alcohol Abuse and Alcoholism (F31AA016704, R01AA014284, P50AA011605, AA 11605, R01AA014949, AA16704, R01AA012655, NIAAA‐AA11605, AA 14949, AA 007573, AA014284, AA-12655, P60AA011605, T32AA007573)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- ethanol withdrawal, anxiety-like behavior, lipopolysaccharide, cytokines, TNF-α, IL-1β, CCL2/MCP-1, flumazenil, benzodiazepine receptor, GABAA receptor, stress, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Ethanol, Analysis of Variance, Animals, Antidotes, Anxiety, Behavior, Animal, Body Weight, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Interactions, Flumazenil, Interpersonal Relations, Lipopolysaccharides, Male, Motor Activity, Substance Withdrawal Syndrome, Time Factors, Cytokines, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Repeated Lipopolysaccharide (LPS) or Cytokine Treatments Sensitize Ethanol Withdrawal-Induced Anxiety-Like Behavior. https://app.cochat.ai/papers/10.1038/sj.npp.1301468
- The paper
- Breese, G. R., Knapp, D. J., Overstreet, D. H., Navarro, M., Wills, T. A., & Angel, R. A. (2008). Repeated Lipopolysaccharide (LPS) or Cytokine Treatments Sensitize Ethanol Withdrawal-Induced Anxiety-Like Behavior. Neuropsychopharmacology. https://doi.org/10.1038/sj.npp.1301468
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.